Procter & Gamble (NYSE:PG) Price Target Raised to $189.00

Procter & Gamble (NYSE:PG) had its price target boosted by BNP Paribas Exane from $177.00 to $189.00 in a research report released on Friday,Benzinga reports. The firm currently has an outperform rating on the stock.

A number of other brokerages also recently weighed in on PG. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Procter & Gamble in a report on Friday. Barclays increased their price target on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Argus downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $149.00 price objective on shares of Procter & Gamble in a research note on Monday, August 24th. Finally, HSBC reiterated a “hold” rating and issued a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Fifteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $168.90.

Procter & Gamble Price Performance

PG stock opened at $161.21 on Friday. The firm has a market cap of $373.64 billion, a price-to-earnings ratio of 24.28, a PEG ratio of 4.00 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $167.25. The company’s fifty day simple moving average is $148.41 and its 200 day simple moving average is $147.12.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company had revenue of $23.28 billion for the quarter, compared to the consensus estimate of $22.80 billion. During the same period in the previous year, the business earned $1.99 EPS. The firm’s revenue was up 4.0% compared to the same quarter last year. On average, analysts expect that Procter & Gamble will post 6.98 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.51%.

Insiders Place Their Bets

In related news, insider Susan Whaley sold 2,369 shares of the company’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the transaction, the insider directly owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew Janzaruk sold 359 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer owned 1,271 shares in the company, valued at approximately $184,600.04. The trade was a 22.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 15,135 shares of company stock worth $2,189,970 over the last three months. Insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of institutional investors have recently modified their holdings of PG. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Procter & Gamble in the 2nd quarter worth $26,000. Montgomery Financial Services LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at $28,000. Paladin Partners LLC bought a new stake in Procter & Gamble during the 2nd quarter valued at $29,000. Toews Corp ADV bought a new stake in Procter & Gamble during the 2nd quarter valued at $37,000. Finally, Evergreen Advisors LLC acquired a new position in Procter & Gamble during the first quarter worth $37,000. 65.77% of the stock is owned by institutional investors and hedge funds.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.